Literature DB >> 10505691

Transglutaminase transcription and antigen translocation in experimental renal scarring.

T S Johnson1, N J Skill, A M El Nahas, S D Oldroyd, G L Thomas, J A Douthwaite, J L Haylor, M Griffin.   

Abstract

It was recently demonstrated that renal tissue transglutaminase (tTg) protein and its catalytic product the epsilon(gamma-glutamyl) lysine protein cross-link are significantly increased in the subtotal (5/6) nephrectomy model (SNx) of renal fibrosis in rats. It was proposed that the enzyme had two important physiologic functions in disease development; one of stabilizing the increased extracellular matrix (ECM) by protein cross-linking, the other in a novel form of tubular cell death. This study, using the same rat SNx model, demonstrates first by Northern blotting that expression of tTg mRNA when compared with controls is increased by day 15 (+70% increase, P < 0.05), then rises steadily, peaking at day 90 (+391%, P < 0.01), and remains elevated at 120 d (+205%, P < 0.05) when compared with controls. In situ hybridization histochemistry demonstrated that the tubular cells were the major site of the additional tTg synthesis. Immunohistochemistry on cryostat sections revealed a sixfold increase (P < 0.001) in ECM-bound tTg antigen at 90-d post-SNx, whereas in situ transglutaminase activity demonstrated by the incorporation of fluorescein cadaverine into cryostat sections indicated a 750% increase (P < 0.001) on day 90 in SNx animals. This increased activity was extracellular and predominantly found in the peritubular region. These results indicate that increased tTg gene transcription by tubular cells underlies the major changes in renal tTg protein reported previously in SNx rats, and that the presence of the epsilon(gamma-glutamyl) lysine cross-links in the extracellular environment is the result of the extracellular action of tTg. These changes may be in response to tubular cell injury during the scarring process and are likely to contribute to the progressive expansion of the ECM in renal fibrosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10505691     DOI: 10.1681/ASN.V10102146

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  26 in total

1.  A crucial sequence for transglutaminase type 2 extracellular trafficking in renal tubular epithelial cells lies in its N-terminal beta-sandwich domain.

Authors:  Che-Yi Chou; Andrew J Streets; Philip F Watson; Linghong Huang; Elisabetta A M Verderio; Timothy S Johnson
Journal:  J Biol Chem       Date:  2011-06-07       Impact factor: 5.157

2.  Syndecan-4 knockout leads to reduced extracellular transglutaminase-2 and protects against tubulointerstitial fibrosis.

Authors:  Alessandra Scarpellini; Linghong Huang; Izhar Burhan; Nina Schroeder; Muriel Funck; Timothy S Johnson; Elisabetta A M Verderio
Journal:  J Am Soc Nephrol       Date:  2013-12-19       Impact factor: 10.121

3.  Cysteamine modulates oxidative stress and blocks myofibroblast activity in CKD.

Authors:  Daryl M Okamura; Nadia M Bahrami; Shuyu Ren; Katie Pasichnyk; Juliana M Williams; Jon A Gangoiti; Jesus M Lopez-Guisa; Ikuyo Yamaguchi; Bruce A Barshop; Jeremy S Duffield; Allison A Eddy
Journal:  J Am Soc Nephrol       Date:  2013-09-05       Impact factor: 10.121

4.  Cross-linking of cellular proteins by tissue transglutaminase during necrotic cell death: a mechanism for maintaining tissue integrity.

Authors:  Ben Nicholas; Peter Smethurst; Elisabetta Verderio; Richard Jones; Martin Griffin
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

5.  Elevated transglutaminase-2 expression mediates fibrosis in areca quid chewing-associated oral submucocal fibrosis via reactive oxygen species generation.

Authors:  Shiuan-Shinn Lee; Yi-Juai Chen; Chung-Hung Tsai; Fu-Mei Huang; Yu-Chao Chang
Journal:  Clin Oral Investig       Date:  2015-09-04       Impact factor: 3.573

6.  Heparan sulfate proteoglycans are receptors for the cell-surface trafficking and biological activity of transglutaminase-2.

Authors:  Alessandra Scarpellini; Renée Germack; Hugues Lortat-Jacob; Takashi Muramatsu; Ellen Billett; Timothy Johnson; Elisabetta A M Verderio
Journal:  J Biol Chem       Date:  2009-04-27       Impact factor: 5.157

7.  Tissue transglutaminase contributes to interstitial renal fibrosis by favoring accumulation of fibrillar collagen through TGF-beta activation and cell infiltration.

Authors:  Nasim Shweke; Nada Boulos; Chantal Jouanneau; Sophie Vandermeersch; Gerry Melino; Jean-Claude Dussaule; Christos Chatziantoniou; Pierre Ronco; Jean-Jacques Boffa
Journal:  Am J Pathol       Date:  2008-08-07       Impact factor: 4.307

8.  Gliadin and tissue transglutaminase complexes in normal and coeliac duodenal mucosa.

Authors:  R Ciccocioppo; A Di Sabatino; C Ara; F Biagi; M Perilli; G Amicosante; M G Cifone; G R Corazza
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

9.  Fibronectin-tissue transglutaminase matrix rescues RGD-impaired cell adhesion through syndecan-4 and beta1 integrin co-signaling.

Authors:  Dilek Telci; Zhuo Wang; Xiaoling Li; Elisabetta A M Verderio; Martin J Humphries; Manuela Baccarini; Huveyda Basaga; Martin Griffin
Journal:  J Biol Chem       Date:  2008-05-22       Impact factor: 5.157

10.  Increased TG2 expression can result in induction of transforming growth factor beta1, causing increased synthesis and deposition of matrix proteins, which can be regulated by nitric oxide.

Authors:  Dilek Telci; Russell John Collighan; Huveyda Basaga; Martin Griffin
Journal:  J Biol Chem       Date:  2009-08-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.